Advertisement

Journal of Neural Transmission

, Volume 126, Issue 12, pp 1589–1597 | Cite as

Mesenchymal stem cells inhibited the inflammation and oxidative stress in LPS-activated microglial cells through AMPK pathway

  • Dayong Cao
  • Haowen Qiao
  • Dejiao He
  • Xingping Qin
  • Qian Zhang
  • Yu ZhouEmail author
Neurology and Preclinical Neurological Studies - Original Article
  • 87 Downloads

Abstract

Microglia are the resident mononuclear immune cells of the central nervous system (CNS) and the activation of microglia contributes to the production of excessive neurotoxic factors. In particular, the overproduction of neurotoxic factors has critical effects on the development of brain injuries and neurodegenerative diseases. The human bone marrow-derived mesenchymal stem cells (hBM-MSCs) have blossomed into an effective approach with great potential for the treatment of neurodegenerative diseases and gliomas. The present study aimed to investigate the mechanism behind the therapeutic effect of hBM-MSCs on the activation of microglia in vitro. Specifically, the hBM-MSCs significantly inhibited the proliferation of lipopolysaccharide-activated microglial cells (LPS)-activated microglial cells. Additionally, we investigated whether the adenosine-monophosphate-activated protein kinase signaling (AMPK) pathway was involved in this process. Our data demonstrated that hBM-MSCs significantly increased the phosphorylated AMPK in LPS-activated microglial cells. In addition, our study indicated the inhibitory effect of hBM-MSCs on the pro-inflammatory mediators and oxidative stress by the AMPK pathway in LPS-activated microglial cells. These results could shed light on the understanding of the molecular basis for the inhibition of hBM-MSCs on LPS-activated microglial cells and provide a molecular mechanism for the hBM-MSCs implication in brain injuries and neurodegenerative diseases.

Keywords

Bone marrow-derived mesenchymal stem cells Activated microglial cells Adenosine-monophosphate-activated protein kinase 

Notes

References

  1. Baron R, Binder A, Wasner G (2010) Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9(8):807–819.  https://doi.org/10.1016/S1474-4422(10)70143-5 CrossRefPubMedGoogle Scholar
  2. Blaylock RL (2017) Parkinson’s disease: microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration. Surg Neurol Int 8:65.  https://doi.org/10.4103/sni.sni_441_16 CrossRefPubMedPubMedCentralGoogle Scholar
  3. Bollinger JL, Bergeon Burns CM, Wellman CL (2016) Differential effects of stress on microglial cell activation in male and female medial prefrontal cortex. Brain Behav Immun 52:88–97.  https://doi.org/10.1016/j.bbi.2015.10.003 CrossRefPubMedGoogle Scholar
  4. Borst K, Schwabenland M, Prinz M (2018) Microglia metabolism in health and disease. Neurochem Int.  https://doi.org/10.1016/j.neuint.2018.11.006 CrossRefPubMedGoogle Scholar
  5. Cabezas R, Baez-Jurado E, Hidalgo-Lanussa O, Echeverria V, Ashraf GM, Sahebkar A, Barreto GE (2018) Correction to: growth factors and neuroglobin in astrocyte protection against neurodegeneration and oxidative stress. Mol Neurobiol.  https://doi.org/10.1007/s12035-018-1257-8 CrossRefPubMedGoogle Scholar
  6. Carniglia L, Ramirez D, Durand D, Saba J, Turati J, Caruso C, Scimonelli TN, Lasaga M (2017) Neuropeptides and microglial activation in inflammation, pain, and neurodegenerative diseases. Mediat Inflamm 2017:5048616.  https://doi.org/10.1155/2017/5048616 CrossRefGoogle Scholar
  7. Chakari-Khiavi F, Dolati S, Chakari-Khiavi A, Abbaszadeh H, Aghebati-Maleki L, Pourlak T, Mehdizadeh A, Yousefi M (2019) Prospects for the application of mesenchymal stem cells in Alzheimer’s disease treatment. Life Sci 231:116564.  https://doi.org/10.1016/j.lfs.2019.116564 CrossRefPubMedGoogle Scholar
  8. Crosas-Molist E, Fabregat I (2015) Role of NADPH oxidases in the redox biology of liver fibrosis. Redox Biol 6:106–111.  https://doi.org/10.1016/j.redox.2015.07.005 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Dheen ST, Kaur C, Ling EA (2007) Microglial activation and its implications in the brain diseases. Curr Med Chem 14(11):1189–1197CrossRefGoogle Scholar
  10. Drela K, Siedlecka P, Sarnowska A, Domanska-Janik K (2013) Human mesenchymal stem cells in the treatment of neurological diseases. Acta Neurobiol Exp 73(1):38–56Google Scholar
  11. Franco R, Fernandez-Suarez D (2015) Alternatively activated microglia and macrophages in the central nervous system. Prog Neurobiol 131:65–86.  https://doi.org/10.1016/j.pneurobio.2015.05.003 CrossRefPubMedGoogle Scholar
  12. Graeber MB, Li W, Rodriguez ML (2011) Role of microglia in CNS inflammation. FEBS Lett 585(23):3798–3805.  https://doi.org/10.1016/j.febslet.2011.08.033 CrossRefPubMedGoogle Scholar
  13. Haslund-Vinding J, McBean G, Jaquet V, Vilhardt F (2017) NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease. Br J Pharmacol 174(12):1733–1749.  https://doi.org/10.1111/bph.13425 CrossRefPubMedGoogle Scholar
  14. Her GJ, Wu HC, Chen MH, Chen MY, Chang SC, Wang TW (2013) Control of three-dimensional substrate stiffness to manipulate mesenchymal stem cell fate toward neuronal or glial lineages. Acta Biomater 9(2):5170–5180.  https://doi.org/10.1016/j.actbio.2012.10.012 CrossRefPubMedGoogle Scholar
  15. Hou L, Wang K, Zhang C, Sun F, Che Y, Zhao X, Zhang D, Li H, Wang Q (2018) Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway. Redox Biol 14:250–260.  https://doi.org/10.1016/j.redox.2017.09.017 CrossRefPubMedGoogle Scholar
  16. Jose S, Tan SW, Ooi YY, Ramasamy R, Vidyadaran S (2014) Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-alpha levels. J Neuroinflamm 11:149.  https://doi.org/10.1186/s12974-014-0149-8 CrossRefGoogle Scholar
  17. Karussis D, Kassis I, Kurkalli BG, Slavin S (2008) Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 265(1–2):131–135.  https://doi.org/10.1016/j.jns.2007.05.005 CrossRefPubMedGoogle Scholar
  18. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91(2):461–553.  https://doi.org/10.1152/physrev.00011.2010 CrossRefPubMedGoogle Scholar
  19. Kumar A, Henry R, Stoica B, Loane D, Abulwerdi G, Bhat S, Faden A (2018) Neutral sphingomyelinase inhibition alleviates LPS induced microglia activation and neuroinflammation after experimental traumatic brain injury. J Pharmacol Exp Ther.  https://doi.org/10.1124/jpet.118.253955 CrossRefPubMedGoogle Scholar
  20. Lee DY, Oh YJ, Jin BK (2005) Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways. Glia 51(2):98–110.  https://doi.org/10.1002/glia.20190 CrossRefPubMedGoogle Scholar
  21. Lewerenz J, Ates G, Methner A, Conrad M, Maher P (2018) Oxytosis/ferroptosis-(Re-) emerging roles for oxidative stress-dependent non-apoptotic cell death in diseases of the central nervous system. Front Neurosci 12:214.  https://doi.org/10.3389/fnins.2018.00214 CrossRefPubMedPubMedCentralGoogle Scholar
  22. Lim SY, Subedi L, Shin D, Kim CS, Lee KR, Kim SY (2017) A new neolignan derivative, balanophonin isolated from firmiana simplex delays the progress of neuronal cell death by inhibiting microglial activation. Biomol Ther 25(5):519–527.  https://doi.org/10.4062/biomolther.2016.224 CrossRefGoogle Scholar
  23. Mukherjee P, Mulrooney TJ, Marsh J, Blair D, Chiles TC, Seyfried TN (2008) Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. Mol Cancer 7:37.  https://doi.org/10.1186/1476-4598-7-37 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, Chang IY, Kim KS, Kim SH (2015) Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl Med 4(6):590–597.  https://doi.org/10.5966/sctm.2014-0212 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Popiolek-Barczyk K, Mika J (2016) Targeting the microglial signaling pathways: new insights in the modulation of neuropathic pain. Curr Med Chem 23(26):2908–2928CrossRefGoogle Scholar
  26. Qiao H, Zhou Y, Qin X, Cheng J, He Y, Jiang Y (2018) NADPH oxidase signaling pathway mediates mesenchymal stem cell-induced inhibition of hepatic stellate cell activation. Stem Cells Int 2018:1239143.  https://doi.org/10.1155/2018/1239143 CrossRefPubMedPubMedCentralGoogle Scholar
  27. Song WM, Colonna M (2018) The microglial response to neurodegenerative disease. Adv Immunol 139:1–50.  https://doi.org/10.1016/bs.ai.2018.04.002 CrossRefPubMedGoogle Scholar
  28. Steens J, Klein D (2018) Current strategies to generate human mesenchymal stem cells in vitro. Stem Cells Int 2018:6726185.  https://doi.org/10.1155/2018/6726185 CrossRefPubMedPubMedCentralGoogle Scholar
  29. Subedi L, Ji E, Shin D, Jin J, Yeo JH, Kim SY (2017) Equol, a dietary daidzein gut metabolite attenuates microglial activation and potentiates neuroprotection in vitro. Nutrients.  https://doi.org/10.3390/nu9030207 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Togna AR, Latina V, Trefiletti G, Guiso M, Moschini S, Togna GI (2013) 1-Phenil-6,7-dihydroxy-isochroman inhibits inflammatory activation of microglia. Brain Res Bull 95:33–39.  https://doi.org/10.1016/j.brainresbull.2013.03.001 CrossRefPubMedGoogle Scholar
  31. Trallori E, Ghelardini C, Di Cesare Mannelli L (2019) Mesenchymal stem cells, implications for pain therapy. Neural Regen Res 14(11):1915–1916.  https://doi.org/10.4103/1673-5374.259615 CrossRefPubMedPubMedCentralGoogle Scholar
  32. Wilhelmsson U, Andersson D, de Pablo Y, Pekny R, Stahlberg A, Mulder J, Mitsios N, Hortobagyi T, Pekny M, Pekna M (2017) Injury leads to the appearance of cells with characteristics of both microglia and astrocytes in mouse and human brain. Cereb Cortex 27(6):3360–3377.  https://doi.org/10.1093/cercor/bhx069 CrossRefPubMedGoogle Scholar
  33. Xue Y, Wang Y, Feng DC, Xiao BG, Xu LY (2008) Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-kappaB pathway. Acta Pharmacol Sin 29(2):245–251.  https://doi.org/10.1111/j.1745-7254.2008.00734.x CrossRefPubMedGoogle Scholar
  34. Yan ZJ, Hu YQ, Zhang HT, Zhang P, Xiao ZY, Sun XL, Cai YQ, Hu CC, Xu RX (2013) Comparison of the neural differentiation potential of human mesenchymal stem cells from amniotic fluid and adult bone marrow. Cell Mol Neurobiol 33(4):465–475.  https://doi.org/10.1007/s10571-013-9922-y CrossRefPubMedGoogle Scholar
  35. Zhai X, Qiao H, Guan W, Li Z, Cheng Y, Jia X, Zhou Y (2015) Curcumin regulates peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression by AMPK pathway in hepatic stellate cells in vitro. Eur J Pharmacol 746:56–62.  https://doi.org/10.1016/j.ejphar.2014.10.055 CrossRefPubMedGoogle Scholar
  36. Zhan L, Krabbe G, Du F, Jones I, Reichert MC, Telpoukhovskaia M, Kodama L, Wang C, Cho SH, Sayed F, Li Y, Le D, Zhou Y, Shen Y, West B, Gan L (2019) Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain. PLoS Biol 17(2):e3000134.  https://doi.org/10.1371/journal.pbio.3000134 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  • Dayong Cao
    • 1
  • Haowen Qiao
    • 2
  • Dejiao He
    • 3
  • Xingping Qin
    • 4
  • Qian Zhang
    • 5
  • Yu Zhou
    • 6
    Email author
  1. 1.Department of BurnsThe First People’s Hospital of ZhengzhouZhengzhouPeople’s Republic of China
  2. 2.School of Basic Medical SciencesWuhan UniversityWuhanPeople’s Republic of China
  3. 3.Department of NephrologyRenmin Hospital of Wuhan UniversityWuhanPeople’s Republic of China
  4. 4.Department of NeurosurgeryRenmin Hospital of Wuhan UniversityWuhanPeople’s Republic of China
  5. 5.Department of OncologyThe First People’s Hospital of ZhengzhouZhengzhouPeople’s Republic of China
  6. 6.Department of NeurosurgeryThe Second Xiangya Hospital of Central South UniversityChangshaPeople’s Republic of China

Personalised recommendations